Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2020 Apr-Jun;34(2):148–155. doi: 10.1097/WAD.0000000000000357

Table 3.

Multivariable generalized linear mixed models of drug or supplement use

Prescription Medication for Dementia Supplements for Memory/
Brain Health
Effect Estimate OR SE p Estimate OR SE p
Intercept −4.81 0.01 0.50 <.0001 −1.75 0.17 0.25 <.0001
Assessment year 0.16 1.17 0.03 <.0001 0.08 1.09 0.02 <.0001
Education HS vs. < HS 0.06 1.06 0.42 0.89 0.38 1.46 0.21 0.07
> HS vs. < HS 0.09 1.09 0.43 0.84 0.56 1.75 0.22 0.01
Sex Female vs. Male −0.31 0.73 0.28 0.27 0.14 1.15 0.13 0.29
Ageatbaseline 75–84 vs. 65–74 −0.2 0.82 0.24 0.41 −0.21 0.81 0.11 0.06
≥ 85 vs. 65–74 −0.5 0.61 0.32 0.12 −0.38 0.69 0.16 0.02
Clinical Dementia Rating (CDR) CDR ≥ 1 vs. CDR = 0 1.82 6.16 0.42 <.0001 −0.43 0.65 0.39 0.26
CDR = 0.5 vs. CDR = 0 1.14 3.13 0.25 <.0001 −0.04 0.96 0.13 0.75
Subjective Memory Complaints (SMC) SMC 3–5 vs. SMC ≤ 2 0.15 1.16 0.21 0.48 −0.07 0.93 0.10 0.48
SMC > 5 vs. SMC ≤ 2 0.26 1.3 0.27 0.33 −0.10 0.90 0.17 0.55
Memory domain composite score −0.6 0.55 0.11 <.0001 0.16 1.17 0.07 0.02
Self-rated heath Good vs. poor/fair 0.21 1.23 0.20 0.31 0.07 1.07 0.11 0.55
Very good/excellent vs. poor/fair 0.11 1.11 0.25 0.66 0.15 1.16 0.13 0.24

Abbreviations: OR, odds ratio; SE, standard error; HS, high school